Literature DB >> 31903377

Intraoperative Management of a Patient for Deep Brain Stimulation with Severe Dyskinesia and Tremors: Ketamine to the Rescue!

Suman Sokhal1, Keshav Goyal1, Navdeep Sokhal1, Niraj Kumar1, Shweta Kedia2.   

Abstract

The loss of dopaminergic neurons from the substantia nigra pars compacta characterizes the classical pathology of Parkinson's disease (PD). Deep brain stimulation (DBS) has become an increasingly common treatment for PD. Sometimes excessive tremors due to exacerbated PD hinder the surgery and may almost make it impossible. This is a case report highlights use of IV ketamine for intraoperative sedation of a patient with PD, with severe dyskinesia & tremors, posted for DBS. IV ketamine resulted in prompt abolition of tremors and dyskinesia, which were unresponsive to previous traditional sedative drugs. Copyright:
© 2019 Asian Journal of Neurosurgery.

Entities:  

Keywords:  Deep brain stimulation; Parkinson's disease; dyskinesia; ketamine; sedation

Year:  2019        PMID: 31903377      PMCID: PMC6896633          DOI: 10.4103/ajns.AJNS_47_18

Source DB:  PubMed          Journal:  Asian J Neurosurg


  7 in total

Review 1.  Parkinson's disease and anaesthesia.

Authors:  G Nicholson; A C Pereira; G M Hall
Journal:  Br J Anaesth       Date:  2002-12       Impact factor: 9.166

Review 2.  Parkinson's disease. First of two parts.

Authors:  A E Lang; A M Lozano
Journal:  N Engl J Med       Date:  1998-10-08       Impact factor: 91.245

Review 3.  Stimulation of basal and L-DOPA-induced motor activity by glutamate antagonists in animal models of Parkinson's disease.

Authors:  M S Starr; B S Starr; S Kaur
Journal:  Neurosci Biobehav Rev       Date:  1997-07       Impact factor: 8.989

4.  Multi-limb acquisition of motor evoked potentials and its application in spinal cord injury.

Authors:  Shrivats Iyer; Anil Maybhate; Alessandro Presacco; Angelo H All
Journal:  J Neurosci Methods       Date:  2010-09-09       Impact factor: 2.390

Review 5.  Rationale for and use of NMDA receptor antagonists in Parkinson's disease.

Authors:  Penelope J Hallett; David G Standaert
Journal:  Pharmacol Ther       Date:  2004-05       Impact factor: 12.310

Review 6.  Intravenous sub-anesthetic ketamine for perioperative analgesia.

Authors:  Andrew W Gorlin; David M Rosenfeld; Harish Ramakrishna
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2016 Apr-Jun

7.  Case Reports Showing a Long-Term Effect of Subanesthetic Ketamine Infusion in Reducing l-DOPA-Induced Dyskinesias.

Authors:  Scott J Sherman; Miguel Estevez; Ari B Magill; Torsten Falk
Journal:  Case Rep Neurol       Date:  2016-02-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.